IRIS Accounts Production v24.3.2.46 10720849 Board of Directors 1.5.23 30.4.24 30.4.24 false true false false false false 74511 74511 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh107208492023-04-30107208492024-04-30107208492023-05-012024-04-30107208492022-04-30107208492022-05-012023-04-30107208492023-04-3010720849ns15:EnglandWales2023-05-012024-04-3010720849ns14:PoundSterling2023-05-012024-04-3010720849ns10:Director12023-05-012024-04-3010720849ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3010720849ns10:Micro-entities2023-05-012024-04-3010720849ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3010720849ns10:FullAccounts2023-05-012024-04-301072084912023-05-012024-04-3010720849ns10:Director2422023-05-012024-04-3010720849ns10:Director2422024-04-3010720849ns5:CurrentFinancialInstruments2024-04-3010720849ns5:CurrentFinancialInstruments2023-04-3010720849ns5:Non-currentFinancialInstruments2024-04-3010720849ns5:Non-currentFinancialInstruments2023-04-3010720849ns10:RegisteredOffice2023-05-012024-04-3010720849ns10:Director22023-05-012024-04-30107208491ns10:Director12023-04-30107208491ns10:Director12022-04-30107208491ns10:Director12023-05-012024-04-30107208491ns10:Director12022-05-012023-04-30107208491ns10:Director12024-04-30107208491ns10:Director12023-04-30
REGISTERED NUMBER: 10720849 (England and Wales)












Plymouth Vein Clinic Limited

Unaudited Financial Statements

for the Year Ended 30 April 2024






Plymouth Vein Clinic Limited (Registered number: 10720849)






Contents of the Financial Statements
for the Year Ended 30 April 2024




Page

Statement of Financial Position 1


Plymouth Vein Clinic Limited (Registered number: 10720849)

Statement of Financial Position
30 April 2024

2024 2023
£    £    £    £   
FIXED ASSETS 156,468 119,142

CURRENT ASSETS 153,597 60,148

CREDITORS
Amounts falling due within one year (72,178 ) (94,447 )
NET CURRENT ASSETS/(LIABILITIES) 81,419 (34,299 )
TOTAL ASSETS LESS CURRENT LIABILITIES 237,887 84,843

CREDITORS
Amounts falling due after more than one year 91,578 25,189
NET ASSETS 146,309 59,654

CAPITAL AND RESERVES 146,309 59,654

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Plymouth Vein Clinic Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 10720849

Registered office: Unit 2 Dunheved Court
Pennygillam Way
Pennygillam Industrial Estate
LAUNCESTON
Cornwall
PL15 7ED

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 4 (2023 - 4 ) .

3. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 April 2024 and 30 April 2023:

2024 2023
£    £   
S Ashley and Mrs N S Ashley
Balance outstanding at start of year - -
Amounts advanced 74,511 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 74,511 -

The overdrawn directors loan accounts are being repaid by way of a dividend within 9 mohts of the year end. Interest has been applied at HMRC's approved rates on the overdrawn amounts.

Plymouth Vein Clinic Limited (Registered number: 10720849)

Statement of Financial Position - continued
30 April 2024

NOTES TO THE FINANCIAL STATEMENTS

4. OTHER FINANCIAL COMMITMENTS

The company has a two year lease commitment with £9,314 of commitments remaining.



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 15 January 2025 and were signed on its behalf by:





S Ashley - Director